liver cancer
【医学口语】肝癌 Liver Cancer(中英)

【医学口语】肝癌 Liver Cancer(中英) Liver CancerThere is no consensus regarding the optimal treatment of patients with liver tumors. This contributes to the pessimistic attitude that many have regarding the treatment of liver cancer. Aggressive treatment strategies can cure or significantly prolong the life of many patients with liver cancer.The liver is a common site of metastases from a variety of organs such as lung, breast, colon and rectum. When liver metastases occur at the time of initial diagnosis of the primary tumor, they are described as synchronous. If detected after the initial diagnosis, they are described as metachronous. The liver is frequently involved since it receives blood from the abdominal organs via the portal vein. Malignant cells detach from the primary cancer, enter the bloodstream or lymphatic channels, travel to the liver, and grow independently. We do not understand the mechanism of how a tumor cell can leave the primary site and grow in specific organs. Potentially, the environment of the liver is suitable to the growth of certain tumor cells. Once a tumor begins to grow in the liver, it receives its blood supply from the hepatic artery.肝癌对肝癌的治疗有分歧。
肝癌病人健康宣教内容

肝癌病人健康宣教内容English.I. Introduction.Liver cancer is the sixth leading cause of cancer-related deaths worldwide, with a high incidence in developing countries. The main risk factors for liver cancer include chronic hepatitis B or C infection, alcohol abuse, and non-alcoholic fatty liver disease.II. Pathophysiology.Liver cancer can develop from hepatocytes (the main liver cells) or bile duct cells. The most common type of liver cancer is hepatocellular carcinoma (HCC), which arises from hepatocytes. HCC typically occurs in patients with cirrhosis, a condition in which the liver is scarred and damaged.III. Symptoms.Liver cancer often does not cause symptoms in its early stages. As the tumor grows, symptoms may develop, such as:Abdominal pain or discomfort.Jaundice (yellowing of the skin and eyes)。
Fatigue.Weight loss.Nausea and vomiting.Swollen abdomen.Ascites (fluid accumulation in the abdomen)。
医学课件:肝细胞癌(英文版)

– Medial survival 62m – 5-year survval rate:50.6%
P<0.000r for incidence of HCC in carriers than non carriers
• Hepatitis C: leading cause of HCC in Western countries and Japan
• Aflatoxin B: synergistic factor with HBV in China and subSaharan Africa
Diagnosis
• American Association for the study of liver Diseases (AASLD)
– Lesion 1.0cm, with HCC features (enhancement in artery phase and washout in venous phase) on one of Dynamic imagines (CT or MRI)
Hepatocellular carcinoma
Epidemiology
• HCC is the seventh most common cancer worldwide, and the third leading cause of cancerrelated deaths.
• More than 600,000 new cases worldwide annually (50% in China)
transplantation surgical resection
samll liver cancer large liver cancer
英语常见疾病英文 (1).docx

常见疾病Common Diseases1.癌症cancer2.肠癌cancer of the intestine3.肺癌lung cancer4.肝癌liver cancer5.食管癌cancer of esophagus6.胃癌gastric carcinoma7.胰腺癌cancer of the pancreas8.子宫颈癌cancer of the cervix9.鼻炎rhinitis10.鼻窦炎sinusitis11.扁桃体炎tonsillitis12.病毒性心肌炎viral myocarditis13.肠胃炎enterogastritis14.胆囊炎cholecystitis15.蜂窝组织炎cellulitis16.风湿性关节炎rheumarthritis17.腹膜炎peritonitis18.关节炎arthritis19.肺炎pneumonia20.睾丸炎orchitis21.宫颈炎cervicitis22.巩膜炎scleritis23.过敏性鼻炎allergic rhinitis24.喉炎laryngitis25.急性胃炎acute gastritis26.脊髓灰质炎poliomyelitis/ infantile paralysis27.甲沟炎paronychia28.角膜炎keratitis29.腱鞘炎tenosynovitis30.接触性皮炎dermatitis31.结肠炎colitis32.结膜炎conjunctivitis33.口角炎angular stomatitis34.泪腺炎dacryoadenitis35.流行性脑膜炎epidemic encephalitis36.流行性腮腺炎mumps37.流行性乙型肝炎epidemic hepatitis B38.阑尾炎appendicitis39.卵巢炎oophoritis40.面神经炎facial neuritis41.脑膜炎cerebral meningitis42.黏膜炎catarrh43.尿道炎urethritis44.膀胱炎urocystitis45.盆腔炎pelvic inflammatory disease46.皮炎dermatitis47.气管炎tracheitis48.前列腺炎prostatitis49.乳腺炎mastitis50.腮腺炎parotiditis51.神经炎neuritis52.神经性皮炎neurodermatitis53.肾炎nephritis54.肾盂肾炎pyelonephritis55.食管炎esophagus56.输卵管炎salpingitis57.外耳炎otitis externa58.胃炎gastritis59.牙髓炎pulpitis60.牙周炎periodontitis61.牙龈炎gingivitis62.咽炎pharyngitis63.阴道炎vaginitis64.支气管炎bronchitis65.中耳炎otitis media66.艾滋病AIDS67.白化病albinism68.白血病leukemia69.败血病septicemia70.风湿病rheumatism71.疯牛病mad cow disease72.高血压hypertension73.冠心病coronary heart disease74.黑死病black death75.黄热病yellow fever76.蛔虫病ascariasis77.结核病tuberculosis78.精神病insanity79.佝偻病richets/ rickets80.狂犬病rabies81.痨病phtisis82.淋病gonorrhoea83.慢性肺源性心脏病chronic cor pulmonale84.皮肤真菌病dermatomycosis85.伤科病disease of the traumatology86.糖尿病diabetes87.外科病surgical diseases88.胃病gastropathy89.心脏病heart disease90.性病veneral disease91.癔症hysteria92.硬皮病scleroderma93.偏头痛migraine/ splitting headache94.三叉神经痛trigeminal95.神经痛neuralgia96.头痛headache97.心绞痛angina pectoris98.坐骨神经痛sciatica99.流产abortion100.习惯性流产habitual abortion 101.先兆流产threatened abortion 102.自然流产miscarriage103.恶性肿瘤malignant tumor 104.骨瘤osteoma105.良性肿瘤benign tumor106.神经瘤neuroma107.脂肪瘤lipoma/ adipoma108.肿瘤tumor109.胆石症cholelithiasis110.肥胖症obesity111.精神分裂症schizophrenia112.神经过敏症neuroticism113.厌食症anorexia114.抑郁症depression115.营养不良症malnutrition116.中风后遗症sequela of wind stroke 117.白喉diphtheria118.白癜风vitiligo119.白内障cataract120.百日咳whooping cough121.斑疹伤寒typhus122.鼻子过敏nasal allergy123.扁桃体肥大hypertrophy of tonsils 124.便秘constipation125.不孕sterility126.痤疮acne127.带状疱疹zona128.丹毒erysipelas129.单纯性肥胖simple obesity 130.癫痫epilepsy131.冻伤frostbite132.非典SARS/ Severe Acute Respiratory Syndrome 133.痱子prickly heat/ sudamen134.肺结核pulmonary tuberculosis135.肺脓肿pulmonary136.肺气肿pulmonary emphysema137.粉碎性骨折comminuted fracture138.风湿热rheumatic fever139.风疹German measles140.肝硬化cirrhosis141.肝肿大hepatomegaly142.感冒,伤风,着凉cold143.肛裂anal fissure144.肛瘘anal fistula145.高脂血症hyperlipidemia146.鼓膜穿孔performation of the tympanic membrane 147.骨折fracture148.红斑狼疮lupus erythematosus149.坏疽gangrene150.黄疸jaundice151.黄褐斑chloasma152.霍乱cholera153.晕厥syncope154.甲状腺功能亢进hyperthyroidosis155.甲状腺肿goitre156.疥疮scabies157.精神错乱mental disorder158.近视near sight159.开放性骨折open fracture/ compound fracture 160.咳嗽cough161.口疮aphtha162.流感influenza/ flu163.痢疾dysentery164.麻痹paralysis165.麻疹measles166.马耳他热Malta fever167.麦粒肿sty168.慢性菌痢chronic bacillary dysentery169.梅毒syphilis170.面瘫facial paralysis171.尿崩症diabetes insipidus172.牛皮藓psoriasis173.疟疾malaria174.偏瘫hemiplegia175.皮肤过敏allergic skin reaction176.贫血anemia/ anaemia177.葡萄胎hydatidiform mole178.破伤风tetanus179.青光眼glaucoma180.禽流感bird flu/ avian influenza181.褥疮bedsore/ pressure score182.沙眼trachoma183.烧伤burn184.上呼吸道感染upper respiratory infection 185.神经衰弱neurasthenia186.肾结石kidney stone187.湿疹eczema188.水痘chicken pox, varicella189.天花smallpox190.痛风gout191.胃溃疡gastric ulcer192.胃下垂gastroptosis193.消化不良indigestion194.小儿肌性斜颈infantile myogenic torticollis 195.哮喘asthma196.斜颈torticollis/ wryneck197.心肌梗死miocardial infarction198.心律不齐arrhythmia199.猩红热scarlet fever200.夏季热summer heat201.血栓形成thrombosis202.荨麻疹urticaria203.癣tinea/ ringworm204.阳痿impotence205.羊水过多hydramnios206.遗精emission207.遗尿enuresis208.婴儿腹泻infantile diarrhea209.营养不良malnutrition210.再生障碍性贫血aplastic anemia211.早产premature labor212.沼地热swamp fever213.支气管哮喘bronchitic asthma214.重症肌无力myasthenia gravis215.子宫出血metrorrhagia216.子痫eclampsia217.痔疮hemorrhoid。
livercancer-肝癌

Infections
• Hepatitis B virus • Hepatitis C virus • Cirrhosis Alcohol induced • Autoimmune hepatitis • Primary biliary cirrhosis Environmental • Aflatoxins • Pyrrolizidine
• If typical features appear on imaging, the diagnosis of HCC is confirmed.
• If atypical features are seen, then biopsy is required to confirm the histologic diagnosis.
people with primary liver cancer have elevated levels
• Ultrasound of the abdomen Computed tomography (CT or CAT) scan
• Magnetic resonance imaging (MRI)
and tumor
MALIGNANT TUMORS OF LIVER
• HEPATOCELLULAR CARCINOMA • CHOLANGIOCARCINOMA • HEPATOBLASTOMA • HEPTIC ANGIOSARCOMA
HEPATOCELLULAR CARCINOMA
• Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer.
肝癌流行病学英文版(匹兹堡癌症中心).

Ethnic and familial clustering have been reported
› Possible interaction between Hepatitis infection and a major gene
Implicated as the probable cause of HCC in at least 80% of cases worldwide
Vaccination
› 90% preventable with proper use of hepatitis B vaccine
› Universal immunization of newborns in Taiwan is associated with at least a 50% reduction in incidence of HCC among adolescents
5 year survival rate is approximately 6.9%
One of the most common malignancies in eastern Asia and sub-Saharan Africa
Incidence up to 90.0/100,000 in some parts of the world
› Part of WHO universal childhood vaccination
› Cost reduced from $100 to $1 per pediatric dose
Major viral cause of liver cancer in areas with low HBV prevalence
肝癌

流行病学特征 (epidemiology character)
●男女比例(inverse proportion of man and woman)
●自然生存期(nature survival time)
●综合治疗的效果(五年生存率)
(synthesis therapeutic effect)
肝脏的解剖位置及功能
临床表现
( clinical representation)
●体征 ۞肝脏肿大 ۞黄疸 ۞腹水(ascites) ۞肝掌、蜘蛛痣 (spider naevi)
临床表现 ( clinical representation)
●体征 ۞血管杂音(souffle of vein) ۞锁骨上淋巴结肿大 ۞乳腺增大 ۞皮肤、牙龈出血
治疗措施 (therapy measure)
二、放射治疗 原发性肝癌对放疗不甚敏感,且邻近 器官易受放射损害,故疗效不够满意,近 年来由于定位诊断方法改进。采用60钴局 部照射,对肝功能较好且能耐受4.000rad 以上的剂量者,疗效显著提高。随着放射 能源的更新,放疗效果继续提高,如目前 采用直线加速器,疗效比使用60钴更好。
۞组织学检查
诊断(diagnosis)
●病理诊断 肝组织学检查证实为原发性肝癌;肝外组 织的组织学检查证实为肝细胞癌;胸腹腔积液 找到肝癌细胞。 ●临床诊断 ۞无其它肝癌证据,AFP对流法阳性或 放免法≥400μg/L,持续4周以上,并能排除妊 娠、活动性肝病、生殖腺胚胎源性肿瘤及转移 性肝癌者。
诊断(diagnosis)
●临床诊断
۞影像学检查有明确肝内实质性占位病变,能排 除肝血管瘤和转移性肝癌,并具有下列条件之一者: 1.AFP≥ 200μg/L; 2. 典型的原发性肝癌影像学表现; 3.无黄疸而AKP或γ-GT明显升高; 4.远处有明确的转移性病灶或有血性腹水,或在 腹水中找到癌细胞; 5.明确的乙型肝炎标志性的肝硬化。
肝癌 肝脏肿瘤cancer of the liver

1肝癌介绍肝癌介绍肝癌是指发生于肝脏的恶性肿瘤,包括原发性肝癌和转移性肝癌两种,人们日常说的肝癌指的多是原发性肝癌。
原发性肝癌是临床上最常见的恶性肿瘤之一,根据最新统计,全世界每年新发肝癌患者约六十万,居恶性肿瘤的第五位。
原发性肝癌按细胞分型可分为肝细胞型肝癌、胆管细胞型肝癌及混合型肝癌。
按肿瘤的形态可分为结节型、巨块型和弥漫型。
原发性肝癌在我国属于高发病,一般男性多于女性。
中国是乙肝大国,我国的肝癌多在乙肝肝硬化的基础上发展而来,丙肝病人也在逐渐增加,乙肝后也会发展为肝癌。
目前我国发病人数约占全球的半数以上,占全球肝癌病人的55%,已经成为严重威胁我国人民健康和生命的一大杀手,其危险性不容小视。
2肝癌发病原因肝癌发病原因1、病毒性肝炎:流行病学统计表明,乙肝流行的地区也是肝癌的高发地区,患过乙肝的人比没有患过乙肝的人患肝癌的机会要高10倍之多。
长期的临床观察中发现,肝炎、肝硬化、肝癌是不断迁移演变的三部曲。
近来研究表明,与肝癌有关的病毒性肝炎主要包括乙型肝炎(HBV)、丙型肝炎(BCV),而其中又以乙型肝炎最为常见。
2、酒精:俗话说“饮酒伤肝”,饮酒并不是肝癌的直接病因,但它的作用类似于催化剂,能够促进肝癌的发生和进展。
有长期酗酒嗜好者容易诱发肝癌。
这是因为酒精进入人体后,主要在肝脏进行分解代谢,酒精对肝细胞的毒性使肝细胞对脂肪酸的分解和代谢发生障碍,引起肝内脂肪沉积而造成脂肪肝。
饮酒越多,脂肪肝也就越严重,进而引起肝纤维化、肝硬化、肝癌的发生。
如果肝炎患者再大量酗酒,会大大加快加重肝硬化的形成和发展,促进肝癌的发生。
3、饮食相关因素:肝癌的发生与生活习惯息息相关。
长期进食霉变食物、含亚硝胺食物、微量元素硒缺乏也是促发肝癌的重要因素。
黄曲霉毒B1是目前已被证明有明确致癌作用的物质,主要存在于霉变的粮食中,如玉米、花生、大米等。
另外当摄食大量的含有亚硝酸盐的食物,亚硝酸盐在体内蓄积不能及时排出,可以在体内转变成亚硝胺类物质,亚硝酸盐含量较高的食物以烟熏或盐腌的肉制品为著,具有明确的致癌作用。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
J Hepatobiliary Pancreat Surg (2003) 10:288–291DOI 10.1007/s00534-002-0732-8Intrahepatic cholangiocarcinoma: macroscopic type and stage classificationS usumu Y amasakiDepartment of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuou-ku, Tokyo 104-0045, Japannumber of patients with ICC at an operable stage has been increasing. ICC has wide variations in clinico-pathologic features. When we surgeons construct a strategy of operation for ICC, we have to understand the clinical type of ICC. A macroscopic type classifica-tion for ICC has been desired.A staging system for primary liver cancer was first published in 1987 by the International Union Against Cancer (UICC) in the third version of the TNM classi-fication, which was followed, in the latest, fifth version,with minor amendments. This system of staging in-cluded both hepatocellular carcinoma (HCC) and ICC.But this system was established considering only HCC,which accounts for more than 90% of primary liver cancers. The biological behaviors of HCC and ICC are different. The oncologic natures of the two primary can-cers are different. A classification for TNM staging spe-cific to ICC has been desired, and the Liver Cancer Study Group of Japan (LCSGJ) intended to establish an ICC staging system. In 1992, the LCSGJ organized a committee to establish a macroscopic type classification and a staging system for ICC. The author played the role of chairman of the ICC committee, and here we propose classifications of macroscopic type and a stag-ing system for ICC.Among cholangiocarcinomas, ICC is defined as that which originates at the second branch (segmental branch) or the proximal branch of the bile duct.2Cholangioma that originates at the hepatic duct (the first branch, lobular branch of the bile duct) or at the common bile duct is defined as extrahepatic cholangiocarcinoma.Macroscopic type of ICC Materials and methodsThe ICC committee of the LCSGJ collected 245resected cases of ICC from the leading institutes ofAbstractThe Liver Cancer Study Group of Japan established a classification of macroscopic type and the TNM staging of intrahepatic cholangiocarcinoma (ICC). With the observation of more than 240 resected cases of ICC, three fundamental types were established. They were: (1) mass-forming (MF)type, (2) periductal-infiltrating (PI) type, and (3) intraductal growth (IG) type. The MF type forms a definite mass, located in the liver parenchyma. The PI type is defined as ICC which extends mainly longitudinally along the bile duct, often result-ing in dilatation of the peripheral bile duct. The IG type proliferates toward the lumen of the bile duct papillarily or like a tumor thrombus. The TNM classification of ICC was then designed, using 136 cases of the MF type resected cura-tively between 1990 and 1996 at member institutes. Univariate and multivariate analyses showed: (1) tumor 2cm or less, (2)single nodule, and (3) no vascular and serous membrane inva-sion as prognostic factors. T factors were defined as follows:T1 is an ICC that meets all requirements of factors (1), (2),and (3); T2 meets two of the three requirements, T3 meets one of the three requirements and T4 meets none of the three requirements. Our data did not support the idea that the hepatoduodenal lymph node is regional. The N factors were defined as N0 no lymph node metastasis; and N1, positive at any nodes. Thus, the stages of ICC were defined as stage I,T1N0M0; stage II, T2N0M0; stage III, T3N0M0; stage IVA,T4N0M0 or any TN1M0; and stage IVB, any T any NM1.Key words Intrahepatic cholangiocarcinoma · Macroscopic type · TNM classificationBackgroundAlthough intrahepatic cholangiocarcinoma (ICC) ac-counts for only 5% or less of primary liver cancers 1 in recent years, with advances in diagnostic modalities, the Offprint requests to: S. YamasakiReceived: March 20, 2002 / Accepted: April 15, 2002hepatic surgery in Japan for macroscopic type classifica-tion. The cases were classified according to the macro-scopic shape on the largest cross-section of the operative specimen, and after long discussion and de-bate, three fundamental types were established. ResultsThe three basic types of ICC were: (1) mass-forming (MF) type, (2) periductal-infiltrating (PI) type, and (3) intraductal growth (IG) type.2 The schematic and basic forms of the three types are shown in Fig. 1. The MF type forms a definite round-shaped mass, located in the liver parenchyma, and not invading a major branch of the portal triad. The PI type is characterized by tumor that extends mainly longitudinally along the bile duct, often resulting in dilatation of the peripheral bile duct. The tumor mass itself is often not visualized by imagings. The IG type proliferates toward the lumen of the bile duct papillarily or like a tumor thrombus, occa-sionally involving superficial extension. This type of ICC is usually detected in a thick bile duct. “Unclassi-fied” was added as a fourth category. When the tumor has more than one component of the three basic types, the predominant type is described first and the less dominant component follows, connected by “ϩ” , e.g.,“MF ϩ PI”. Some clinical examples of the three macro-scopic types are shown in Fig. 2.Staging system for ICCMaterials and methodsIn 1996, the ICC committee of the LCSGJ started work to establish a TNM classification of ICC. For this pur-pose, the committee collected resected cases of ICC from the member institutes of the committee. Consider-ing the rapid advances in diagnostic imaging modalities,the eligibility criteria of the cases for this study were as follows: (1) cases resected between 1990 and 1996, (2) resection was curable, and (3) cases without distant metastasis. A total of 173 cases eligible according to the criteria were obtained from nine institutes. Of the cases collected in this study, the number of cases of each macroscopic type were: 136, 27, and 10 for the MF type (including MF-dominant type), PI type, and IG type, respectively. In this study, for the staging system, the cases of PI and IG types of ICC were excluded because of the small number of cases. So this staging system for ICC was applied just to the MF type, tentatively. ResultsSeveral anatomic prognostic factors related to cancer were identified by univariate and multivariate analyses. Factors related to host (sex, age, liver function, and others) and treatment (surgical margin, extent of resec-tion, and others) were not significant. Tumor size 2cm or less (hazard ratio [HR], 2.39; 95% confidence inter-val [CI], 18.06–0.32), lymph node metastasis (HR, 2.36; 95% CI, 4.33–1.28), number of nodules, solitary or mul-tiple (HR, 1.93; 95% CI, 3.18–1.17), serous membrane invasion (HR, 2.19; 95% CI, 3.60–1.33), portal vein in-vasion (HR, 1.68; 95% CI, 2.88–0.98), and hepatic vein invasion (HR, 1.18; 95% CI, 2.16–0.65) were judged to be statistically significant positive factors for predicting death. On the basis of the results above, T factors were proposed, as follows: T1 is a tumor that is (1) solitary, (2) 2cm or less, and (3) without portal and hepatic vein and serous membrane invasion. T2 is a tumor with two of these three requirements, T3 is a tumor with one of these three requirements, and T4 is a tumor with noneof these three requirements (Table 1). The TNMintrahepatic cholangiocarcinomaT FactorT1: meets all three requirements below.T2: meets two of the three requirements below.T3: meets one of the three requirements below.T4: meets none of the three requirements below.Requirements DescriptionNumber of tumors SolitarySize of tumor2cm or lessNegative invasion Portal vein, hepatic vein, serousmembraneN FactorN1: no metastasis to lymph node.N0: metastasis to any lymph nodes.M FactorM0: no distant metastasis.M1: positive distant metastasis.Fig. 1.Three fundamental macroscopic types of intrahepaticcholangiocarcinoma. 1, mass-forming type; 2, periductal-infiltrating type; 3, intraductal growth typeclassification of the UICC defines the regional lymph nodes of the liver as those at the liver hilum and the hepatoduodenal ligament. In this study, it was sug-gested that lymph node metastasis is a strong prognostic factor of ICC; however, it could not be documented that regional lymph nodes as defined by the UICC were the most frequent sites of metastasis, and the prognosis of the patients with positive regional lymph node metasta-sis (N1) was better than that of patients with positive distant lymph node metastasis (N2). Only the fact that any positive lymph node metastasis made the prognosis of the patient definitely worse than negative lymph Fig. 2a–e.Examples of three macroscopic types of intrahepatic cholangiocarcinoma. a Mass-forming type. b Periductal-infiltrating type: computed tomographic view. Marked dilatation of bile duct is seen (see d), but tumor itself is not recognized. c Panoramic view of the site of stricture and beginning of dilatation of the bile duct of the case shown in b and d. The cancer cells covered the epithelium of the bile duct. d Operative specimen of the case shown in b. The tumor is not recognized by macroscopic observation. e Intraductal growth typea b c d enode metastasis was certain. Thus, new T and N classifications were proposed, as noted in Table 1, and a new staging system was proposed, as noted in Table 2.The survival rates of ICC patients who underwent cura-tive resection are shown in Fig. 3.DiscussionA macroscopic type is recognized visually, not by quan-titative judgment. The classification of the macroscopic type was determined rather subjectively. We expect this classification of macroscopic type to be evaluated after many clinicians have used this classification.In the past, articles that mentioned prognostic factors of ICC treated surgically were few.3–5 The number of cases analyzed in the past articles was 30 or less, which was not enough to reach a definite conclusion. As the oncologic behaviors of the two primary cancers, HCC and ICC, are different, we anticipated that the appear-ance of the new staging system for ICC may be different from that for HCC. Contrary to our expectations, the classification of the TNM staging for ICC proposed here is similar to that for HCC. The difference was that se-rous membrane invasion was a positive prognostic fac-tor in ICC, but not in HCC. Vascular invasion was apositive prognostic factor in both HCC and ICC; how-ever, we have to understand that the modes of vascular invasion of HCC and ICC are different, as HCC forms a tumor thrombus in vascular structures, whereas ICC infiltrates into the walls of vessels. With the HCC stag-ing system, there are three types each of T2 and of T3.Most T2 types are those with solitary tumor more than 2cm and without vascular invasion. The other two types of T2, “multiple tumors 2cm or less and without vascu-lar invasion” and “solitary tumor 2cm or less with vas-cular invasion” were not found in our series. In regard to T3, the type with multiple tumors 2cm or less with vascular invasion, was also not found in our series. The current TNM classification of liver cancer defines the lymph nodes at the liver hilum and at the hepato-duodenal ligament as regional lymph nodes. Nozaki et al.6 reported that the lymph node metastasis pattern of the UICC TNM classification, at least with respect to the regional lymph nodes, should be reconsidered. In this study, we also did not find any reason why the regional lymph nodes of primary liver cancer should be defined as the lymph nodes at the hepatoduodenal ligament.As shown in Fig. 3, the differences in survival rates between any two neighboring stages are not always sig-nificant. The number of cases of ICC that can be col-lected by a single institute, especially resectable cases,has been too small to be analysed statistically. Although this was a multiinstitutional study, the number of the subjects was still not enough to obtain a statistically significant difference. But separation of the survival curves was appropriate. We are tentatively using this staging system for ICC, and in future some correction may be needed.References1.Liver Cancer Study Group of Japan (2000) The 14th report, sur-veillance of primary liver cancer patients in National Registry.LCSGJ, Kyoto, p 252.Liver Cancer Study Group of Japan (1997) Intrahepatic cholangiocarcinoma, macroscopic typing. In: Okamoto E (eds)Classification of primary liver cancer. Kanehara, Tokyo, pp 6–73.Valverde A, Bonhomme N, Farges O, Sauvanet A, Flejou JF,Belghiti J (1999) Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg 6:122–1274.Lieser MJ, Barry MK, Rowland C, Ilstrup DM, Nagorney DM (1998) Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. J Hepatobiliary Pancreat Surg 5:41–475.Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE (1998) Liver resection for hilar and peripheral cholangiocar-cinomas: a study of 62 cases. Ann Surg 227:70–796.Nozaki Y, Yamamoto M, Ikai I, Yamamoto Y, Ozaki N, Fujii H,Nagahori K, Matsumoto Y, Yamaoka Y (1998) Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma. Cancer 83:1923–1929Table 2.Proposed staging system for intrahepatic cholangiocarcinomaTN M Stage I T1N0M0Stage II T2N0M0Stage III T3N0M0State IVA T4N0M0Or any T N1M0Stage IVBAny TAny NM1Fig. 3.Survival rates of intrahepatic cholangiocarcinoma (ICC) according to the proposed TNM classification. n.s ., Not significant。